Saturday, September 5, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 9, 2025

Fed likely to cut rates at Dec. meeting, Paramount's hostile bid for WBD

View original at finance.yahoo.com
Fed likely to cut rates at Dec. meeting, Paramount's hostile bid for WBD Morning Brief host Julie Hyman tackles the biggest market stories ahead of the opening bell on December 9, 2025…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Lot of money chasing few good deals leading to acceptance of previously unacceptable terms

    80% confidence
  • Fed will temper sentiment on rate cuts next year but investors need to watch labor market commentary

    80% confidence
  • Consumers remain intentional in their shopping behaviors but stand to benefit from at-home cooking trends

    80% confidence
  • CVS is closing out the year with meaningful momentum across its business

    80% confidence
  • Heavy debt load on Warner Bros from acquisition could challenge their ability to be successful

    80% confidence
  • Risk level today has gone up quite a bit with people thinking deals can't fail

    80% confidence
  • Fed will cut 25 basis points but signal fewer cuts going forward in hawkish manner

    80% confidence
  • Investors need to sort of sit tight as we go into 2026

    80% confidence
  • Kevin Hassett is favorite to become new Fed chair in May

    80% confidence
  • Seeing exotic financial deals reminiscent of 1980s excess with private credit

    80% confidence
  • Bitcoin could end the year below $100,000 despite earlier estimates of $150,000-$200,000

    80% confidence
  • To prevent China outpacing US in AI, US needs to be participant in China market

    80% confidence
  • Intel and AMD would also be eligible for modified chip sales to China

    80% confidence
  • Short term Bitcoin holders have cost basis around $103,000 and tend to sell on rises

    80% confidence
  • Supreme Court majority seemed in favor of giving Trump more power to remove independent agency personnel

    80% confidence
  • Allowing Nvidia into China will slow down domestic Chinese competition

    80% confidence
  • Huawei is about 2 to 5 years behind Nvidia currently

    80% confidence
  • 25 basis point cut is important for investor sentiment, not necessarily for companies

    80% confidence
  • Market is definitely expecting a cut and is addicted to having this cut

    80% confidence
  • Competition is critical for advanced technologies and giving China competitive access will propel market forward

    80% confidence
  • Trump informed Chinese President Xi Jinping about Nvidia chip approval and Xi responded favorably

    80% confidence
  • CVS expects earnings to grow again in 2026

    80% confidence
  • Hawkish Fed cut would not be good for crypto in general

    80% confidence
  • Referenced Tricolor bankruptcy as potential cockroach signal for credit markets

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com
Fed likely to cut rates at Dec. meeting, Paramount's hostile bid for WBD — Source | Via News | Via News